Cargando…

Plitidepsin: a Repurposed Drug for the Treatment of COVID-19

Finding antivirals to reduce coronavirus disease 2019 (COVID-19) morbidity and mortality has been challenging. Large randomized clinical trials that aimed to test four repurposed drugs, hydroxychloroquine, lopinavir-ritonavir, interferon beta 1a, and remdesivir, have shown that these compounds lack...

Descripción completa

Detalles Bibliográficos
Autor principal:	Martinez, Miguel Angel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097422/ https://www.ncbi.nlm.nih.gov/pubmed/33558296 http://dx.doi.org/10.1128/AAC.00200-21

Ejemplares similares

Plitidepsin for multiple myeloma
Publicado: (2019)

Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment
por: Martinez, Miguel Angel
Publicado: (2021)

Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen
por: Rodon, Jordi, et al.
Publicado: (2021)

Plitidepsin: design, development, and potential place in therapy
por: Alonso-Álvarez, Sara, et al.
Publicado: (2017)

Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
por: Galmarini, Carlos M., et al.
Publicado: (2014)

Clinical Trials of Repurposed Antivirals for SARS-CoV-2
por: Martinez, Miguel Angel
Publicado: (2020)

Repurposed drugs for COVID-19: threshold and proof requirements for trials
por: Paul, Mical, et al.
Publicado: (2021)

Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19
por: Varona, Jose F, et al.
Publicado: (2022)

Buying time: Drug repurposing to treat the host in COVID‐19H
por: Martin, Jennifer H., et al.
Publicado: (2020)

Efficacy of repurposed antiviral drugs: Lessons from COVID-19
por: Martinez, Miguel Angel
Publicado: (2022)

Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19
por: Papapanou, Michail, et al.
Publicado: (2021)

Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
por: Araki, Wataru
Publicado: (2013)

Repurposing biomedical informaticians for COVID-19
por: Sosa, Daniel N., et al.
Publicado: (2021)

Plitidepsin Has a Safe Cardiac Profile: A Comprehensive Analysis
por: Soto-Matos, Arturo, et al.
Publicado: (2011)

Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis
por: Varona, Jose F., et al.
Publicado: (2023)

Repurposing an HIV Drug for Zika Virus Therapy
por: Xie, Xuping, et al.
Publicado: (2019)

DRUG REPURPOSING—Overcoming the translational hurdles to clinical use
por: Martin, Jennifer H., et al.
Publicado: (2019)

Repurposing drugs for treatment of COVID-19
por: Venkatesan, Priya
Publicado: (2021)

Drug repurposing for the treatment of COVID-19
por: Kato, Yuri, et al.
Publicado: (2022)

Repurposing COVID-19 Drive-Through Testing Centers for Mass Vaccination
por: Kim, Edward
Publicado: (2020)

Phase I–II study of plitidepsin and dacarbazine as first-line therapy for advanced melanoma
por: Plummer, R, et al.
Publicado: (2013)

c-Jun N-Terminal Kinase Phosphorylation Is a Biomarker of Plitidepsin Activity
por: Muñoz-Alonso, María J., et al.
Publicado: (2013)

COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help
por: Lentini, Giovanni, et al.
Publicado: (2020)

Repurposing Existing Drugs for the Treatment of COVID-19
por: Farne, Hugo, et al.
Publicado: (2020)

Repurposed GI Drugs in the Treatment of COVID-19
por: Aguila, Enrik John T., et al.
Publicado: (2020)

Is metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19?
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Phase I study of plitidepsin in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma
por: Mateos, María Victoria, et al.
Publicado: (2022)

Informatics-guided drug repurposing for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Kiseleva, Anna A., et al.
Publicado: (2020)

Repurposing Anti-Cancer Drugs for COVID-19 Treatment
por: Borcherding, Nicholas, et al.
Publicado: (2020)

An Overview of Repurposed Drugs for Potential COVID-19 Treatment
por: Govender, Kamini, et al.
Publicado: (2022)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Can an FDA-Approved Alzheimer’s Drug Be Repurposed for Alleviating Neuronal Symptoms of Zika Virus?
por: Sirohi, Devika, et al.
Publicado: (2017)

Towards the network-based prediction of repurposed drugs using patient-specific metabolic models
por: Pacheco, Maria Pires, et al.
Publicado: (2019)

Network analytics for drug repurposing in COVID-19
por: Siminea, Nicoleta, et al.
Publicado: (2021)

Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps
por: Abbruzzese, Claudia, et al.
Publicado: (2020)

Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?
por: Devaux, Christian A., et al.
Publicado: (2021)

Unraveling the antiviral activity of plitidepsin against SARS-CoV-2 by subcellular and morphological analysis
por: Sachse, Martin, et al.
Publicado: (2022)

A new screening method for ATP-independent kinase inhibitors identifies repurposed anti-cancer drugs()
por: Timaner, Michael, et al.
Publicado: (2018)

Repurposing exercise training and pharmacological therapies to address the post-acute sequelae of COVID-19 (PASC) in diabetes mellitus
por: Jie Chee, Ying, et al.
Publicado: (2023)

Drug repurposing strategies for COVID-19
por: Senanayake, Suranga L
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dkujbvbd59klgijs4d5uh8keot